Plerixafor Salvage Is Safe and Effective in Hard-to-Mobilize Patients Undergoing Chemotherapy and Filgrastim-Based Peripheral Blood Progenitor Cell Mobilization

Por Awan, Farrukh T., Kochuparambil, S. Thomas, DeRemer, David, Cumpston, Aaron, Craig, Michael, Jillella, Anand, Hamadani, Mehdi
Publicado em 2012

Managing acute promyelocytic leukemia in patients belonging to the Jehovah’s Witness congregation

Por Jillella, Anand P., Arellano, Martha L., Heffner, Leonard T., Gaddh, Manila, Langston, Amelia A., Khoury, Hanna J., Mangoankar, Abhishek, Kota, Vamsi K.
Publicado no Hematol Rep (2017)

Exploratory study on the impact of switching to nilotinib in 18 patients with chronic myeloid leukemia in chronic phase with suboptimal response to imatinib

Por Ailawadhi, Sikander, Akard, Luke P., Miller, Carole B., Jillella, Anand, DeAngelo, Daniel J., Ericson, Solveig G., Lin, Felice, Warsi, Ghulam, Radich, Jerald
Publicado no Ther Adv Hematol (2016)

A novel immunohistochemical score to predict early mortality in acute myeloid leukemia patients based on indoleamine 2,3 dioxygenase expression

Por Mangaonkar, Abhishek, Mondal, Ashis Kumar, Fulzule, Sadanand, Pundkar, Chetan, Park, Eun Jeong, Jillella, Anand, Kota, Vamsi, Xu, Hongyan, Savage, Natasha M., Shi, Huidong, Munn, David, Kolhe, Ravindra
Publicado no Sci Rep (2017)

Co-treatment with vorinostat enhances activity of MK-0457 (VX-680) against acute and chronic myelogenous leukemia cells

Por Fiskus, Warren, Wang, Yongchao, Joshi, Rajeshree, Rao, Rekha, Yang, Yonghua, Chen, Jianguang, Kolhe, Ravindra, Balusu, Ramesh, Eaton, Kelly, Lee, Pearl, Ustun, Celalettin, Jillella, Anand, Buser, Carolyn A., Peiper, Stephen, Bhalla, Kapil
Publicado em 2008

Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phase III double-blind crossover study (N01CB)

Por Cheville, Andrea L., Sloan, Jeff A., Northfelt, Donald W., Jillella, Anand P., Wong, Gilbert Y., Bearden, James D., Liu, Heshan, Schaefer, Paul L., Marchello, Benjamin T., Christensen, Bradley J., Loprinzi, Charles L.
Publicado no Support Care Cancer (2009)

Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells

Por Fiskus, Warren, Wang, Yongchao, Sreekumar, Arun, Buckley, Kathleen M., Shi, Huidong, Jillella, Anand, Ustun, Celalettin, Rao, Rekha, Fernandez, Pravina, Chen, Jianguang, Balusu, Ramesh, Koul, Sanjay, Atadja, Peter, Marquez, Victor E., Bhalla, Kapil N.
Publicado em 2009

Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative neopla...

Por Wang, Yongchao, Fiskus, Warren, Chong, Daniel G., Buckley, Kathleen M., Natarajan, Kavita, Rao, Rekha, Joshi, Atul, Balusu, Ramesh, Koul, Sanjay, Chen, Jianguang, Savoie, Andrew, Ustun, Celalettin, Jillella, Anand P., Atadja, Peter, Levine, Ross L., Bhalla, Kapil N.
Publicado em 2009